[en] Involvement of the AP-1 (activator protein-1) transcription factor has been demonstrated previously in the regulation of cell proliferation and cell-cycle progression, in the control of cell migration, invasion and metastasis, and in signal transduction, stress responsiveness, DNA replication and DNA repair. YB-1 (Y-box-binding protein-1) has also been implicated in many of these processes. However, the mechanism by which YB-1 mediates these processes is poorly understood. In the present study, we report that overexpression of a transfected gene encoding YB-1 in human HeLa cervical carcinoma cells significantly represses the transactivation of a minimal AP-1 reporter construct in response to the tumour promoter PMA. YB-1 also represses mRNA expression and PMA-induced promoter transactivation of the endogenous AP-1 target gene encoding matrix metalloproteinase-12 (metalloelastase). YB-1 transrepression of both the minimal and matrix metalloproteinase-12 promoter reporter constructs is dependent on the AP-1 sequence. To identify new nuclear proteins that bind specifically to the AP-1 DNA-binding site, we devised a DNA-affinity-chromatography-based assay termed NAPSTER (nucleotide-affinity preincubation specificity test of recognition) and discovered a 49 kDa protein from human cancer cells that binds in a sequence-specific manner to the AP-1 DNA sequence. By tandem MS fragmentation sequencing analyses we determined that p49 is a YB-1. Immunoblotting of the NAPSTER-purified p49 protein using anti-YB-1 antibodies confirmed YB-1 binding to the AP-1 DNA sequence, as did gel mobility-supershift assays using YB-1 antibodies. This is the first report of YB-1 transrepression and interaction at the AP-1 DNA-binding site.
Eferl, R. and Wagner, E. F. (2003) AP-1: a double-edged sword in tumorigenesis. Nat. Rev. Cancer 3, 859-868
Shaulian, E. and Karin, M. (2002) AP-1 as a regulator of cell life and death. Nat. Cell Biol. 4, E131-E136
Kohno, K., Izumi, H., Uchiumi, T., Ashizuka, M. and Kuwano, M. (2003) The pleiotropic functions of the Y-box-binding protein, YB-1. Bioessays 25, 691-698
Jurchott, K., Bergmann, S., Stein, U., Walther, W., Janz, M., Manni, I., Piaggio, G., Fietze, E., Dietel, M. and Royer, H. D. (2003) YB-1 as a cell cycle-regulated transcription factor facilitating cyclin A and cyclin B1 gene expression. J. Biol. Chem. 278, 27988-27996
Kuwano, M., Uchiumi, T., Hayakawa, H., Ono, M., Wada, M., Izumi, H. and Kohno, K. (2003) The basic and clinical implications of ABC transporters, Y-box-binding protein-1 (YB-1) and angiogenesis-related factors in human malignancies. Cancer Sci. 94, 9-14
Huber, E., Vlasny, D., Jeckel, S., Stubenrauch, F. and Iftner, T. (2004) Gene profiling of cottontail rabbit papillomavirus-induced carcinomas identifies upregulated genes directly involved in stroma invasion as shown by small interfering RNA-mediated gene silencing. J. Virol. 78, 7478-7489
Zucker, S. and Vacirca, J. (2004) Role of matrix metalloproteinases (MMPs) in colorectal cancer. Cancer Metastasis Rev. 23, 101-117
Kumar, N. V. and Bernstein, L. R. (2001) A new analytical scale DNA affinity binding assay for analyses of specific protein-DNA interactions. Anal. Biochem. 299, 203-210
Kumar, N. V. and Bernstein, L. R. (2001) Ten ERK-related proteins in three distinct classes associate with AP-1 proteins and/or AP-1 DNA. J. Biol. Chem. 276, 32362-32372
Bernstein, L. R. and Walker, S. E. (1999) Tumor promotion resistant cells are deficient in AP-1 DNA binding, JunD DNA binding, and JunD expression and form different AP-1 DNA complexes than promotion sensitive cells. Biochim. Biophys. Acta 1489, 263-280
Ohga, T., Koike, K., Ono, M., Makino, Y., Itagaki, Y., Tanimoto, M., Kuwano, M. and Kohno, K. (1996) Role of the human Y box-binding protein YB-1 in cellular sensitivity to the DNA-damaging agents cisplatin, mitomycin C, and ultraviolet light. Cancer Res. 56, 4224-4228
Feinberg, M. W., Jain, M. K., Werner, F., Sibinga, N. E., Wiesel, P., Wang, H., Topper, J. N., Perrella, M. A. and Lee, M. E. (2000) Transforming growth factor-beta 1 inhibits cytokine-mediated induction of human metalloelastase in macrophages. J. Biol. Chem. 275, 25766-25773
Young, M. R., Nair, R., Bucheimer, N., Tulsian, P., Brown, N., Chapp, C., Hsu, T. and Colburn, N. H. (2002) Transactivation of Fra-1 and consequent activation of AP-1 occur extracellular signal-regulated kinase dependently. Mol. Cell. Biol. 22, 587-598
Powers, C., Krutzsch, H. and Gardner, K. (1996) Modulation of JunD.AP-1 DNA binding activity by AP-1-associated factor 1 (AF-1). J. Biol. Chem. 271, 30089-30095
Philips, A., Teyssier, C., Galtier, F., Rivier-Covas, C., Rey, J. M., Rochefort, H. and Chalbos, D. (1998) FRA-1 expression level modulates regulation of activator protein-1 activity by estradiol in breast cancer cells. Mol. Endocrinol. 12, 973-985
Samuel, S. and Bernstein, L. R. (2004) Adhesion, migration, transcriptional, interferon-inducible, and other signaling molecules newly implicated in cancer susceptibility and resistance of JB6 cells by cDNA microarray analyses. Mol. Carcinog. 39, 34-60
Gimenez-Bonafe, P., Fedoruk, M. N., Whitmore, T. G., Akbari, M., Ralph, J. L., Ettinger, S., Gleave, M. E. and Nelson, C. C. (2004) YB-1 is upregulated during prostate cancer tumor progression and increases P-glycoprotein activity. Prostate 59, 337-349
Lee, W., Mitchell, P. and Tjian, R. (1987) Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements. Cell (Cambridge, Mass.) 49, 741-752
Izumi, H., Imamura, T., Nagatani, G., Ise, T., Murakami, T., Uramoto, H., Torigoe, T., Ishiguchi, H., Yoshida, Y., Nomoto, M. et al. (2001) Y box-binding protein-1 binds preferentially to single-stranded nucleic acids and exhibits 3′→5′ exonuclease activity. Nucleic Acids Res. 29, 1200-1207
Wisdom, R. (1999) AP-1: one switch for many signals. Exp. Cell Res. 253, 180-185
Bader, A. G., Felts, K. A., Jiang, N., Chang, H. W. and Vogt, P. K. (2003) Y box-binding protein 1 induces resistance to oncogenic transformation by the phosphatidylinositol 3-kinase pathway. Proc. Natl. Acad. Sci. U.S.A. 100, 12384-12389
Binder, C., Marx, D., Binder, L., Schauer, A. and Hiddemann, W. (1996) Expression of Bax in relation to Bcl-2 and other predictive parameters in breast cancer. Ann. Oncol. 7, 129-133
Zeng, L., Rowland, R. G., Lele, S. M. and Kyprianou, N. (2004) Apoptosis incidence and protein expression of p53, TGF-beta receptor II, p27Kip1, and Smad4 in benign, premalignant, and malignant human prostate. Hum. Pathol. 35, 290-297
Higashi, K., Inagaki, Y., Fujimori, K., Nakao, A., Kaneko, H. and Nakatsuka, I. (2003) Interferon-g interferes with transforming growth factor-b signaling through direct interaction of YB-1 with Smad3. J. Biol. Chem. 278, 43470-43479
Angel, P., Imagawa, M., Chiu, R., Stein, B., Imbra, R. J., Rahmsdorf, H. J., Jonat, C., Herrlich, P. and Karin, M. (1987) Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans acting factor. Cell (Cambridge, Mass.) 49, 729-739
Bos, T. J. (1988) v-jun encodes a nuclear protein with enhancer binding properties of AP-1. Cell (Cambridge, Mass.) 52, 705-712
Chinekov, Y. and Kerppola, T. K. (2001) Close encounters of many kinds: Fos-Jun interactions that mediate transcription regulatory specificity. Oncogene 20, 2438-2452
Motohashi, H., O'Connor, T., Katsuoka, F., Engel, J. D. and Yamamoto, M. (2002) Integration and diversity of the regulatory network composed of Mal and CNC families of transcription factors. Gene 294, 1-12
Hasegawa, H., Utsunomiya, Y., Kishimoto, K., Tange, Y., Yasukawa, M. and Fujita, S. (1996) SFA-2, a novel bZIP transcription factor induced by human T-cell leukemia virus type I, is highly expressed in mature lymphocytes. Biochem. Biophys. Res. Commun. 222, 164-170
Bower, K. E., Zeller, R. W., Wachsman, W., Martinez, T. and McGuire, K. L. (2002) Correlation of transcriptional repression by p21(SNFT) with changes in DNA.NF-AT complex interactions. J. Biol. Chem. 277, 34967-34977
Farrell, P. J., Rowe, D. T., Rooney, C. M. and Kouzarides, T. (1989) Epstein-Barr virus BZLF1 trans-activator specifically binds to a consensus AP-1 site and is related to c-fos. EMBO J. 8, 127-132
Almawi, W. Y. and Melemedjian, O. K. (2002) Molecular mechanisms of glucocorticoid antiproliferative effects: antagonism of transcription factor activity by glucocorticoid receptor. J. Leukoc. Biol. 71, 9-15
Altucci L. and Gronemeyer, H. (2001) The promise of retinoids to fight against cancer. Nat. Rev. Cancer. 1, 181-193
Bode, A. M. and Dong, Z. (2000) Signal transduction pathways: targets for chemoprevention of skin cancer. Lancet Oncol. 1, 181-188